BRCA2 and cancer: Among them, MYC (n = 132), RICTOR (n = 73), EGFR (n = 68), CCNE1 (n = 64), LAMP1 (n = 61), and BRCA2 (n = 54) were the most frequently amplified genes in cancers harboring TP53 mutations (Figure 5A).